logo
  

BPCE Sells 12.2% Stake In Nexity To Two Institutional Investors And New Port

Nexity SA, a French residential and commercial real estate developer, announced Monday the sale by CE Holding Promotion (Groupe BPCE) of 12.2 percent of Nexity's share capital to two institutional investors and New Port SAS.

Groupe BPCE has sold 5.5 million shares representing 10.2 percent of Nexity's share capital to two major French institutional investors - Crédit Agricole Assurance, through its unit Predica, and Crédit Mutuel Arkéa on the basis of a sale price of 35.5 euros per Nexity share ex-dividend 2014.

BPCE also sold 290,000 shares representing 0.54 percent of Nexity's share capital to New Port, a company chaired by Alain Dinin, Nexity's Chairman and CEO, and controlled by Nexity's managers, alongside Crédit Mutuel Arkéa. The operation will be completed on May 27.

Furthermore, New Port has undertaken, subject to financing, to acquire from BPCE up to 802,000 additional shares representing a maximum of 1.48 percent of Nexity's share capital, at the same share price. This additional acquisition will occur by July 8 at the latest.

Once these operations are completed, New Port will have individually crossed the threshold of 5 percent of Nexity's share capital, while the concert group formed by New Port, Crédit Mutuel Arkéa and 188 Nexity key managers and employees would hold about 17.43 percent of the share capital.

New Port has stated that it intends to keep its stake over the long term.

Groupe BPCE, which has 3 representatives on Nexity's Board of Directors, has indicated that it would give up 2 seats in keeping with the reduction of its holding.

Nexity noted that its management will propose to its Board of Directors that those vacated seats be offered to a representative of Crédit Agricole Assurances and a representative of Crédit Mutuel Arkéa.

In Paris, Nexity shares were trading at 38.20 euros, up 0.39 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT